l'Améliane

L'Ameliane SAS operates as a specialized investment company, directing capital towards the medical sector. The firm functions as a strategic financial partner, providing funding and expertise to support the development and commercialization of innovative medical technologies and devices. This focused approach cultivates growth across the healthcare industry.

Established on May 15, 2000, L'Ameliane SAS was founded by President Francois Regis Ory. His insight stemmed from a deep understanding of the medical landscape, recognizing the critical need for targeted investment to foster groundbreaking advancements. The firm’s origins are rooted in facilitating promising medical innovations.

L'Ameliane SAS primarily serves medical technology companies, empowering them to bring their solutions to market and expand their reach. By strategically deploying capital, the firm aims to accelerate the development of pioneering medical solutions. Its long-term vision centers on contributing to significant healthcare advancements.